120 related articles for article (PubMed ID: 17593214)
1. Metallothionein overexpression, a highly significant prognostic factor in thin melanoma.
Weinlich G; Zelger B
Histopathology; 2007 Aug; 51(2):280-3. PubMed ID: 17593214
[No Abstract] [Full Text] [Related]
2. Metallothionein-overexpression as a prognostic factor for progression and survival in melanoma. A prospective study on 520 patients.
Weinlich G; Bitterlich W; Mayr V; Fritsch PO; Zelger B
Br J Dermatol; 2003 Sep; 149(3):535-41. PubMed ID: 14510986
[TBL] [Abstract][Full Text] [Related]
3. Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma.
Zhuang L; Scolyer RA; Lee CS; McCarthy SW; Cooper WA; Zhang XD; Thompson JF; Hersey P
Histopathology; 2009 Mar; 54(4):462-70. PubMed ID: 19309398
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients.
Weinlich G; Eisendle K; Hassler E; Baltaci M; Fritsch PO; Zelger B
Br J Cancer; 2006 Mar; 94(6):835-41. PubMed ID: 16508630
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of metallothionein expression in malignant melanoma in Japanese patients.
Sugita K; Yamamoto O; Asahi M
Am J Dermatopathol; 2001 Feb; 23(1):29-35. PubMed ID: 11176049
[TBL] [Abstract][Full Text] [Related]
6. Unusual histological variants of cutaneous malignant melanoma with some clinical and possible prognostic correlations.
Rongioletti F; Smoller BR
J Cutan Pathol; 2005 Oct; 32(9):589-603. PubMed ID: 16176296
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
8. Correlation among metallothionein expression, intratumoural macrophage infiltration and the risk of metastasis in human cutaneous malignant melanoma.
Emri E; Egervari K; Varvolgyi T; Rozsa D; Miko E; Dezso B; Veres I; Mehes G; Emri G; Remenyik E
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e320-7. PubMed ID: 22817475
[TBL] [Abstract][Full Text] [Related]
9. Novel role for RGS1 in melanoma progression.
Rangel J; Nosrati M; Leong SP; Haqq C; Miller JR; Sagebiel RW; Kashani-Sabet M
Am J Surg Pathol; 2008 Aug; 32(8):1207-12. PubMed ID: 18580492
[TBL] [Abstract][Full Text] [Related]
10. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
11. The role of RhoC in growth and metastatic capacity of melanoma.
Boone B; Van Gele M; Lambert J; Haspeslagh M; Brochez L
J Cutan Pathol; 2009 Jun; 36(6):629-36. PubMed ID: 19222696
[TBL] [Abstract][Full Text] [Related]
12. HER3 is a determinant for poor prognosis in melanoma.
Reschke M; Mihic-Probst D; van der Horst EH; Knyazev P; Wild PJ; Hutterer M; Meyer S; Dummer R; Moch H; Ullrich A
Clin Cancer Res; 2008 Aug; 14(16):5188-97. PubMed ID: 18698037
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes.
Satzger I; Völker B; Meier A; Schenck F; Kapp A; Gutzmer R
Am J Surg Pathol; 2007 Aug; 31(8):1175-80. PubMed ID: 17667539
[TBL] [Abstract][Full Text] [Related]
14. Nucleolin protein expression in cutaneous melanocytic lesions.
Mourmouras V; Cevenini G; Cosci E; Epistolato MC; Biagioli M; Barbagli L; Luzi P; Mannucci S; Miracco C
J Cutan Pathol; 2009 Jun; 36(6):637-46. PubMed ID: 19515042
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
Väisänen AH; Kallioinen M; Turpeenniemi-Hujanen T
Hum Pathol; 2008 Mar; 39(3):377-85. PubMed ID: 18187184
[TBL] [Abstract][Full Text] [Related]
16. Cul1 expression is increased in early stages of human melanoma.
Chen G; Cheng Y; Martinka M; Li G
Pigment Cell Melanoma Res; 2010 Aug; 23(4):572-4. PubMed ID: 20518860
[No Abstract] [Full Text] [Related]
17. An unusual squamo-melanocytic tumor of uncertain biologic behavior: a variant of melanoma?
Pouryazdanparast P; Yu L; Johnson T; Fullen D
Am J Dermatopathol; 2009 Jul; 31(5):457-61. PubMed ID: 19542920
[TBL] [Abstract][Full Text] [Related]
18. CD117 (c-KIT) staining in desmoplastic melanoma.
North J
J Cutan Pathol; 2011 Sep; 38(9):753-5. PubMed ID: 21645038
[No Abstract] [Full Text] [Related]
19. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]